Objective
Glioblastoma is the most common and most malignant form of primary brain tumour. It affects both children and adults and remains virtually incurable. As a result, it is a leading cause of cancer-related deaths and more effective therapeutic strategies are urgently needed. Herein, I propose to use an innovative methodology combining high-throughput drug screening, pathway analysis and functional genomics to simultaneously develop new treatment modalities and identify novel therapeutic targets / biomarkers for glioblastoma. Using high-throughput screening based on drug repositioning principles, I will first identify already approved drugs that can increase the efficacy of conventional and targeted therapies for glioblastoma. Taking advantage of the first-class and clinically-relevant models of glioblastoma available in the host institution, I will then evaluate the therapeutic potential of the hit compounds in vivo. In parallel, using pathway analysis tools and the known targets of the hit compounds, I will generate a list of genes potentially involved in treatment resistance in glioblastoma. The significance of these genes will then be validated using RNA interference-based high-throughput screening. Finally, the patho-physiological role of the key genes identified and validated by this approach will be investigated by functional genomics and their prognostic and/or predictive value will be evaluated using the unique collection of clinically-annotated samples from glioblastoma patients available in the host institution. Overall, this research project will lead to the identification and pre-clinical validation of innovative treatment combinations for glioblastoma, and the discovery of novel therapeutic targets and biomarkers to be used in future clinical trials. It will thus increase our understanding of the biology and resistance to therapy of glioblastoma and has the potential to significantly impact on clinical practice and patient outcome.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP7-PEOPLE-2013-IIF
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
13284 Marseille
France
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.